RxDoctor Payments Data

Travis Haldeman, DO

Obstetrics & Gynecology · Portage, INNPI 1033162425

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,750 of the $19,380 with a category attached, or 81.3%. AbbVie accounts for 87.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $10,644 and has fallen 97.2% since, to $297 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,380in general payments, 2019–2025

Across 150 payments — averaging $129.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$17K
  • Intuitive Surgical$1K
  • Astellas Pharma US Inc$228
  • Hologic Sales And Service, LLC$154
  • Bayer$144
  • Sumitomo Pharma America, Inc.$91
  • plus $530 from 17 others

What the payments were for

  • Speaking & faculty fees$15,75081%
  • Travel & lodging$9765%
  • Food & beverage$2,56913%
  • Education$850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,380 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.

See all obstetrics & gynecology providers in Indiana

Medicare billing

Part B allowed, 2024
$11,774
Medicare patients
54
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip34$564
ValacyclovirValacyclovir Hcl21$367
Norethindrone13$255
Silver Sulfadiazine11$157
Fluconazole21$114
Diclofenac Potassium11$69

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Portage

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →